B细胞-话题@MedSci

#B细胞#

314篇内容 | 6274人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273426, encodeId=3a9712e3426a5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nat Med：Axicabtagene ciloleucel作为高危大B细胞淋巴瘤的一线治疗, objectType=article, longId=301401, objectId=a420301401e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a420301401e0, replyNumber=0, likeNumber=80, createdTime=2022-03-24, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a420301401e0, moduleTitle=Nat Med：Axicabtagene ciloleucel作为高危大B细胞淋巴瘤的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a420301401e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273425, encodeId=e3b012e34259e, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：Axicabtagene Ciloleucel作为大B细胞淋巴瘤二线治疗的效果如何？, objectType=article, longId=298992, objectId=90c929899271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c929899271, replyNumber=0, likeNumber=120, createdTime=2022-02-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c929899271, moduleTitle=NEJM：Axicabtagene Ciloleucel作为大B细胞淋巴瘤二线治疗的效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90c929899271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273424, encodeId=12d312e342459, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较, objectType=article, longId=298991, objectId=961f298991d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=961f298991d8, replyNumber=0, likeNumber=85, createdTime=2022-02-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=961f298991d8, moduleTitle=NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=961f298991d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273423, encodeId=8ab612e342367, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：采用Polatuzumab Vedotin治疗初治弥漫性大B细胞淋巴瘤, objectType=article, longId=295542, objectId=e92329554273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92329554273, replyNumber=0, likeNumber=96, createdTime=2022-02-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92329554273, moduleTitle=NEJM：采用Polatuzumab Vedotin治疗初治弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92329554273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273422, encodeId=a5d712e3422d1, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=A&R：PD-1highCXCR5-CD4+外周T辅助细胞克隆扩增对抗核抗体阳性幼年特发性关节炎患者关节B细胞分化的影响, objectType=article, longId=294609, objectId=1bba29460969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bba29460969, replyNumber=0, likeNumber=94, createdTime=2022-01-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bba29460969, moduleTitle=A&R：PD-1highCXCR5-CD4+外周T辅助细胞克隆扩增对抗核抗体阳性幼年特发性关节炎患者关节B细胞分化的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bba29460969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273421, encodeId=065f12e342184, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, objectType=article, longId=292826, objectId=692329282612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=692329282612, replyNumber=0, likeNumber=128, createdTime=2021-12-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=692329282612, moduleTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=692329282612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273420, encodeId=e17d12e34209b, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=A&R: B细胞耗竭通过抑制系统性硬化症小鼠模型中的促纤维化巨噬细胞分化来抑制纤维化, objectType=article, longId=221786, objectId=2e72221e8697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e72221e8697, replyNumber=0, likeNumber=132, createdTime=2021-12-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e72221e8697, moduleTitle=A&R: B细胞耗竭通过抑制系统性硬化症小鼠模型中的促纤维化巨噬细胞分化来抑制纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e72221e8697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273419, encodeId=7ab112e3419f7, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Frontiers in Immunology: CRAC通道控制狼疮性肾炎病原性B细胞的分化, objectType=article, longId=220077, objectId=acbf2200e7a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acbf2200e7a1, replyNumber=0, likeNumber=149, createdTime=2021-11-12, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acbf2200e7a1, moduleTitle=Frontiers in Immunology: CRAC通道控制狼疮性肾炎病原性B细胞的分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acbf2200e7a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273418, encodeId=261312e341833, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Frontiers in Immunology: IL-40：一种新的B细胞相关细胞因子在利妥昔单抗治疗类风湿性关节炎后上调减少，并与疾病活性、自身抗体和NETosis相关, objectType=article, longId=220020, objectId=587a22002088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=587a22002088, replyNumber=0, likeNumber=87, createdTime=2021-11-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=587a22002088, moduleTitle=Frontiers in Immunology: IL-40：一种新的B细胞相关细胞因子在利妥昔单抗治疗类风湿性关节炎后上调减少，并与疾病活性、自身抗体和NETosis相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=587a22002088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273417, encodeId=417d12e3417b3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性, objectType=article, longId=218717, objectId=b364218e1739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b364218e1739, replyNumber=0, likeNumber=91, createdTime=2021-10-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b364218e1739, moduleTitle=AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b364218e1739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273416, encodeId=4f5812e34166a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Annals of the Rheumatic Diseases: 用奥比妥珠单抗清除B细胞治疗增殖性狼疮性肾炎：一项随机、双盲、安慰剂对照试验, objectType=article, longId=218569, objectId=b5782185696e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5782185696e, replyNumber=0, likeNumber=63, createdTime=2021-10-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5782185696e, moduleTitle=Annals of the Rheumatic Diseases: 用奥比妥珠单抗清除B细胞治疗增殖性狼疮性肾炎：一项随机、双盲、安慰剂对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5782185696e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273415, encodeId=daf312e341589, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究, objectType=article, longId=218340, objectId=2dc9218340ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dc9218340ef, replyNumber=0, likeNumber=70, createdTime=2021-10-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dc9218340ef, moduleTitle=Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dc9218340ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273414, encodeId=82f612e34141c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=与年龄相关B细胞功能和分化改变导致狼疮小鼠模型的雌性偏倚, objectType=article, longId=218091, objectId=97b42180915a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b42180915a, replyNumber=0, likeNumber=69, createdTime=2021-10-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b42180915a, moduleTitle=与年龄相关B细胞功能和分化改变导致狼疮小鼠模型的雌性偏倚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b42180915a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273413, encodeId=cacb12e34136f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=B细胞AIM2缺陷可通过调节 Blimp-1-Bcl-6介导的B细胞分化改善系统性红斑狼疮, objectType=article, longId=218022, objectId=417621802206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=417621802206, replyNumber=0, likeNumber=76, createdTime=2021-10-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=417621802206, moduleTitle=B细胞AIM2缺陷可通过调节 Blimp-1-Bcl-6介导的B细胞分化改善系统性红斑狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=417621802206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273412, encodeId=02e612e34129b, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后, objectType=article, longId=217929, objectId=39e621e9297d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39e621e9297d, replyNumber=0, likeNumber=90, createdTime=2021-10-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39e621e9297d, moduleTitle=J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39e621e9297d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273411, encodeId=fa8212e3411c4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Front Immunol ：狼疮性肾炎的B细胞亚群和细胞特征与疾病复发有关, objectType=article, longId=217628, objectId=3d9921e628c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d9921e628c2, replyNumber=0, likeNumber=103, createdTime=2021-09-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d9921e628c2, moduleTitle=Front Immunol ：狼疮性肾炎的B细胞亚群和细胞特征与疾病复发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d9921e628c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273410, encodeId=709712e341010, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nature子刊：康复后仍免疫缺陷，新冠病毒对B细胞到底还做了什么？！, objectType=article, longId=217607, objectId=673d21e607b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=673d21e607b9, replyNumber=0, likeNumber=105, createdTime=2021-09-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=673d21e607b9, moduleTitle=Nature子刊：康复后仍免疫缺陷，新冠病毒对B细胞到底还做了什么？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=673d21e607b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273409, encodeId=c0ae12e34091e, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ARD：慢性皮肤红斑狼疮病人的B细胞都一样吗？, objectType=article, longId=217590, objectId=bd5e21e590b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd5e21e590b2, replyNumber=0, likeNumber=69, createdTime=2021-09-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd5e21e590b2, moduleTitle=ARD：慢性皮肤红斑狼疮病人的B细胞都一样吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd5e21e590b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273408, encodeId=1a1412e34081a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布, objectType=article, longId=217412, objectId=6fdf21e412ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fdf21e412ed, replyNumber=0, likeNumber=71, createdTime=2021-09-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fdf21e412ed, moduleTitle=ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fdf21e412ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273407, encodeId=9d7712e34072d, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Clin Invest：整合甲基化组-转录组分析揭示了婴儿MLL-重排型B细胞急性淋巴母细胞白血病的癌细胞脆弱性, objectType=article, longId=217332, objectId=283721e3323c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=283721e3323c, replyNumber=0, likeNumber=77, createdTime=2021-09-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=283721e3323c, moduleTitle=J Clin Invest：整合甲基化组-转录组分析揭示了婴儿MLL-重排型B细胞急性淋巴母细胞白血病的癌细胞脆弱性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=283721e3323c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang

#B细胞#

Nat Med：Axicabtagene ciloleucel作为高危大B细胞淋巴瘤的一线治疗

2022-03-24

xiaoyeshuang

#B细胞#

NEJM：Axicabtagene Ciloleucel作为大B细胞淋巴瘤二线治疗的效果如何？

2022-02-18

xiaoyeshuang

#B细胞#

NEJM：侵袭性B细胞淋巴瘤的Tisagenlecleucel或标准治疗比较

2022-02-18

xiaoyeshuang

#B细胞#

NEJM：采用Polatuzumab Vedotin治疗初治弥漫性大B细胞淋巴瘤

2022-02-14

xiaoyeshuang

#B细胞#

A&R：PD-1highCXCR5-CD4+外周T辅助细胞克隆扩增对抗核抗体阳性幼年特发性关节炎患者关节B细胞分化的影响

2022-01-25

xiaoyeshuang

#B细胞#

ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应

2021-12-29

xiaoyeshuang

#B细胞#

A&R: B细胞耗竭通过抑制系统性硬化症小鼠模型中的促纤维化巨噬细胞分化来抑制纤维化

2021-12-11

xiaoyeshuang

#B细胞#

Frontiers in Immunology: CRAC通道控制狼疮性肾炎病原性B细胞的分化

2021-11-12

xiaoyeshuang

#B细胞#

Frontiers in Immunology: IL-40：一种新的B细胞相关细胞因子在利妥昔单抗治疗类风湿性关节炎后上调减少，并与疾病活性、自身抗体和NETosis相关

2021-11-11

xiaoyeshuang

#B细胞#

AJRCCM：B细胞去除治疗系统性硬化症相关性肺动脉高压(SSC-PAH)的安全性和有效性

2021-10-18

xiaoyeshuang

#B细胞#

Annals of the Rheumatic Diseases: 用奥比妥珠单抗清除B细胞治疗增殖性狼疮性肾炎：一项随机、双盲、安慰剂对照试验

2021-10-16

xiaoyeshuang

#B细胞#

Ann Hematol：弥漫性大b细胞淋巴瘤诊断1年后幸存者的生活质量: 一项LYSA研究

2021-10-11

xiaoyeshuang

#B细胞#

与年龄相关B细胞功能和分化改变导致狼疮小鼠模型的雌性偏倚

2021-10-05

xiaoyeshuang

#B细胞#

B细胞AIM2缺陷可通过调节 Blimp-1-Bcl-6介导的B细胞分化改善系统性红斑狼疮

2021-10-03

xiaoyeshuang

#B细胞#

J Clin Oncol：DA-EPOCH-R方案治疗原发性纵隔大B细胞淋巴瘤儿童和青少年患者的预后

2021-10-01

xiaoyeshuang

#B细胞#

Front Immunol ：狼疮性肾炎的B细胞亚群和细胞特征与疾病复发有关

2021-09-26

xiaoyeshuang

#B细胞#

Nature子刊：康复后仍免疫缺陷，新冠病毒对B细胞到底还做了什么？！

2021-09-26

xiaoyeshuang

#B细胞#

ARD：慢性皮肤红斑狼疮病人的B细胞都一样吗？

2021-09-26

xiaoyeshuang

#B细胞#

ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布

2021-09-23

xiaoyeshuang

#B细胞#

J Clin Invest：整合甲基化组-转录组分析揭示了婴儿MLL-重排型B细胞急性淋巴母细胞白血病的癌细胞脆弱性

2021-09-21

科室
- - 订阅+
  - 更多科室
工具
服务